Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 223

1.

Mycobacterium tuberculosis infection in pregnant and nonpregnant women infected with HIV in the Women and Infants Transmission Study.

Mofenson LM, Rodriguez EM, Hershow R, Fox HE, Landesman S, Tuomala R, Diaz C, Daniels E, Brambilla D.

Arch Intern Med. 1995 May 22;155(10):1066-72.

PMID:
7748050
2.

Cutaneous anergy in pregnant and nonpregnant women with human immunodeficiency virus.

Eriksen NL, Helfgott AW.

Infect Dis Obstet Gynecol. 1998;6(1):13-7.

3.

Tuberculin skin test reactivity, anergy, and HIV infection in hospitalized patients. Longcope Firm of the Osler Medical Housestaff.

Janis EM, Allen DW, Glesby MJ, Carey LA, Mundy LM, Gopalan R, Chaisson RE.

Am J Med. 1996 Feb;100(2):186-92.

PMID:
8629653
4.

A prospective study of the risk of tuberculosis among HIV-infected patients.

Guelar A, Gatell JM, Verdejo J, Podzamczer D, Lozano L, Aznar E, Miró JM, Mallolas J, Zamora L, González J, et al.

AIDS. 1993 Oct;7(10):1345-9.

PMID:
8267907
5.
6.

Utility of tuberculin and anergy skin testing in predicting tuberculosis infection in human immunodeficiency virus-infected persons in Thailand.

Yanai H, Uthaivoravit W, Mastro TD, Limpakarnjanarat K, Sawanpanyalert P, Morrow RH Jr, Nieburg P.

Int J Tuberc Lung Dis. 1997 Oct;1(5):427-34.

PMID:
9441097
7.

Anergy during pregnancy.

Jackson TD, Murtha AP.

Am J Obstet Gynecol. 2001 May;184(6):1090-2.

PMID:
11349166
8.

Prevalence of and risk factors for tuberculin positivity and skin test anergy in HIV-1-infected and uninfected at-risk women. Women's Interagency HIV Study (WIHS).

Anastos K, Kalish LA, Palacio H, Benson CA, Delapenha R, Chirgwin K, Stonis L, Telzak EE.

J Acquir Immune Defic Syndr. 1999 Jun 1;21(2):141-7.

PMID:
10360806
9.
10.

Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection.

Caiaffa WT, Graham NM, Galai N, Rizzo RT, Nelson KE, Vlahov D.

Arch Intern Med. 1995 Oct 23;155(19):2111-7.

PMID:
7575072
11.

Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005.

Gupta A, Nayak U, Ram M, Bhosale R, Patil S, Basavraj A, Kakrani A, Philip S, Desai D, Sastry J, Bollinger RC; Byramjee Jeejeebhoy Medical College-Johns Hopkins University Study Group.

Clin Infect Dis. 2007 Jul 15;45(2):241-9. Epub 2007 Jun 4.

PMID:
17578786
13.

HIV infection and zidovudine use in childbearing women.

Sia J, Paul S, Martin RM, Cross H.

Pediatrics. 2004 Dec;114(6):e707-12. Epub 2004 Nov 15.

PMID:
15545619
14.

The rate of TB-HIV co-infection depends on the prevalence of HIV infection in a community.

Datiko DG, Yassin MA, Chekol LT, Kabeto LE, Lindtjørn B.

BMC Public Health. 2008 Jul 30;8:266. doi: 10.1186/1471-2458-8-266.

15.

Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Pulmonary Complications of HIV Infection Study Group.

Markowitz N, Hansen NI, Wilcosky TC, Hopewell PC, Glassroth J, Kvale PA, Mangura BT, Osmond D, Wallace JM, Rosen MJ, Reichman LB.

Ann Intern Med. 1993 Aug 1;119(3):185-93.

PMID:
8100692
16.

Tuberculosis skin testing among HIV-infected pregnant women in Miami, 1995 to 1996.

Schulte JM, Bryan P, Dodds S, Potter M, Onorato IM, O'Sullivan MJ.

J Perinatol. 2002 Mar;22(2):159-62.

17.
18.
19.

Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission.

Elzi L, Schlegel M, Weber R, Hirschel B, Cavassini M, Schmid P, Bernasconi E, Rickenbach M, Furrer H; Swiss HIV Cohort Study.

Clin Infect Dis. 2007 Jan 1;44(1):94-102. Epub 2006 Nov 28.

PMID:
17143823
20.

Supplemental Content

Support Center